C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2011
10/26/2011	CN102225930A Method of treatment of age-related macular degeneration(AMD)
10/26/2011	CN101415705B Compounds and methods for inhibiting hepatitis c viral replication
10/26/2011	CN101218238B Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
10/26/2011	CN101070304B Quinoline derivatives and their use as mycrobacterial inhibitors
10/26/2011	CN101010321B Pyrrolo[3,2-B]pyridine derivatives and processes for the preparation thereof
10/25/2011	US8044103 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
10/25/2011	US8044090 N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
10/25/2011	US8044066 Derivatives of pyrrolopyridine-2-carboxamides, preparation thereof and therapeutic application thereof
10/25/2011	US8044062 Substituted pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors of phospatidylinositol 3-kinase alpha
10/25/2011	US8044043 CGRP receptor antagonists
10/25/2011	CA2657355C Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof
10/20/2011	WO2011130478A1 Phthalazin-(2h)-one inhibitors of kinases
10/20/2011	WO2011130342A1 FUSED DERIVATIVES AS ΡI3Κδ INHIBITORS
10/20/2011	WO2011128455A1 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
10/20/2011	WO2011128421A1 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors
10/20/2011	WO2011128420A1 Pyridyl-vinyl pyrazoloquinolines as par1 inhibitors
10/20/2011	WO2011128316A1 Azacyclic spiroderivatives as hsl inhibitors
10/20/2011	WO2011128251A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011	WO2011128017A1 Bridged triarylamines and -phosphines as materials for electronic devices
10/20/2011	WO2011101304A3 Piperidine derivatives
10/20/2011	WO2011092293A3 Cyclohexyl amide derivatives as crf receptor antagonists
10/20/2011	WO2011064156A3 Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl} carbamate and its purification for use thereof as pharmaceutical substance
10/20/2011	US20110257402 Pyrrazolopyridine compounds as dual nk1/nk3 receptor antagonists
10/20/2011	US20110257400 Materials and methods for the preparation of anisotropically-ordered solids
10/20/2011	US20110257221 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
10/20/2011	US20110257212 New azacyclic derivatives
10/20/2011	US20110257207 Raf inhibitors
10/20/2011	US20110257198 Piperidine derivatives useful as orexin antagonists
10/20/2011	US20110257193 Fused imidazole derivatives as trpv3 antagonist
10/20/2011	US20110257171 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
10/20/2011	US20110257170 4-morpholino-pyrido[3,2-d]pyrimidines
10/20/2011	US20110257169 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
10/20/2011	US20110257153 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
10/20/2011	US20110257152 Pyrrolopyridine inhibitors of kinases
10/20/2011	US20110257151 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011	US20110256064 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
10/20/2011	US20110253944 Novel organic semiconductor compound, method for preparing same, and organic semiconductor composition, and organic semiconductor thin film and element containing the same
10/20/2011	CA2796311A1 Fused derivatives as pi3k.delta. inhibitors
10/20/2011	CA2795387A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011	CA2795101A1 Azacyclic spiroderivatives as hsl inhibitors
10/20/2011	CA2794859A1 Phthalazin-(2h)-one inhibitors of kinases
10/20/2011	CA2794808A1 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
10/19/2011	EP2377860A1 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
10/19/2011	EP2377851A1 Isoquinoline derivative
10/19/2011	EP2377398A1 16-ketoaspergillimide and pest exterminating agent comprising the same as active ingredient
10/19/2011	EP2376495A2 Compositions of protein receptor tyrosine kinase inhibitors
10/19/2011	EP2376490A1 Imidazopyridine compounds
10/19/2011	EP2376485A1 Pyrazine derivatives useful as inhibitors of atr kinase
10/19/2011	EP2376478A2 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
10/19/2011	EP2376454A2 Inhibitors of diacylglycerol acyltransferase
10/19/2011	EP2376449A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
10/19/2011	EP2376407A1 Benzoindenochrysene compound and organic light-emitting device using the same
10/19/2011	EP2376080A1 Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
10/19/2011	EP2375899A1 Piperidine-containing compounds and use thereof
10/19/2011	EP2225245B1 N-phenyl-imidazo(1,2-a)pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
10/19/2011	EP2098522B1 Compounds having affinity for amyloid
10/19/2011	EP1966209B1 [ 1h- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders
10/19/2011	EP1896473B1 1-[[2-amino-3-(substituted alkyl)-3h-benzimidazolyl]methyl]-3-subtituted-1,3-dihydro-benzoimidazol-2-ones as inhibitors of respiratory syncytial virus replication
10/19/2011	EP1648870B1 Sulfonic acid derivatives of polycyclic dyes used for analytical applications
10/19/2011	EP1494671B1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists
10/19/2011	CN1906161B N-sulfonyldicarboximide containing tethering compounds
10/19/2011	CN1251097B Phthalazines with angiogenesis inhibiting activity
10/19/2011	CN102224154A Beta-carboline sulphonylurea derivatives as ep4 receptor antagonists
10/19/2011	CN102224153A Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors
10/19/2011	CN102224152A Pyrazolopyridine pi3k inhibitor compounds and methods of use
10/19/2011	CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011	CN102219786A Preparation method of sparteine
10/19/2011	CN102219772A Cortex pseudolaricis acid complex with bioactivity and preparation method thereof
10/19/2011	CN101421267B Process for the preparation of pyridine heterocycle cgrp antagonist intermediate
10/19/2011	CN101268073B Heterocyclic compound, and production process and use thereof
10/19/2011	CN101223166B Thiazolyl MGLUR5 antagonists and methods for their use
10/19/2011	CN101107247B Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes
10/18/2011	US8039625 Coronene charge-transport materials, methods of fabrication thereof, and methods of use thereof
10/18/2011	US8039618 Method for producing bicyclic guanidines by use of a cyclic urea
10/18/2011	US8039498 Imidazole compounds
10/18/2011	US8039486 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS
10/18/2011	US8039481 Tetrahydrofuran derivatives for use as inhibitors of matrix metalloproteinases
10/18/2011	US8039471 Aza spiro alkane derivatives as inhibitors of metalloproteases
10/18/2011	US8039467 Compounds for the treatment of inflammatory disorders
10/18/2011	CA2515197C Pyrazolopyridine derivates
10/18/2011	CA2508341C Processes for preparing quinolonecarboxylate derivatives
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/13/2011	WO2011126969A1 Prodrugs of an hiv reverse transcriptase inhibitor
10/13/2011	WO2011125911A1 Metal complexes and anticancer agents comprising same as active ingredient
10/13/2011	WO2011125627A1 Rare-earth metal complex
10/13/2011	WO2011124539A1 Bicyclic pyrimidinyl pyrazoles
10/13/2011	WO2011124093A1 Bicyclic quinolone compounds, preparation methods and uses thereof
10/13/2011	WO2011082266A3 Substituted heterocyclic compounds
10/13/2011	WO2011058498A3 Polymorphs of nevirapine and method for increasing the solubility of a transcriptase inhibitor composition
10/13/2011	WO2011038086A3 Indolizine inhibitors of 5-lipoxygenase
10/13/2011	US20110251394 Novel organic compound
10/13/2011	US20110251223 CGRP Receptor Antagonists
10/13/2011	US20110251202 1,3-Dihydro-imidazo[4,5-c]quinolin-2-ones as Lipid Kinase Inhibitors
10/13/2011	US20110251194 Antineoplastic derivatives, preparation thereof and therapeutic use thereof
10/13/2011	US20110251178 Bicyclic Pyridinylpyrazoles
10/13/2011	US20110248251 Nitrogen-containing heterocyclic derivative and organic electroluminescence element using nitrogen-containing heterocyclic derivative
10/13/2011	CA2795523A1 Bicyclic pyrimidinyl pyrazoles
10/13/2011	CA2795514A1 Novel hypoglycemic compounds
10/12/2011	EP2374806A1 OXAZOLIDINON-QUINOLONe HYBRIDes and intermediates for their preparation

1 ... 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 ... 646